Growth and sexual maturation in a 2-year, open-label clinical study of lisdexamfetamine dimesylate in children and adolescents with ADHD

被引：0
|
作者：
Otero, I. Hernandez [1 ]
Banaschewski, T. [2 ]
Johnson, M. [3 ]
Nagy, P. [4 ,5 ,6 ]
Soutullo, C. A. [7 ]
Zuddas, A. [8 ]
Yan, B. [9 ]
Coghill, D. R. [10 ]
机构：
[1] Hosp Virgen de la Victoria, Unit Child & Adolescent Mental Hlth USMIJ, Malaga, Spain
[2] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Mannheim, Germany
[3] Gothenburg Univ, Sahlgrenska Acad, Gillberg Neuropsychiat Ctr, Gothenburg, Sweden
[4] Vadaskert Child & Adolescent Psychiat Hosp, Budapest, Hungary
[5] Vadaskert Child & Adolescent Psychiat Hosp, Outpatient Clin, Budapest, Hungary
[6] Outpatient Clin, Budapest, Hungary
[7] Univ Navarra Clin, Child & Adolescent Psychiat Unit, Dept Psychiat & Med Psychol, Pamplona, Spain
[8] Univ Cagliari, Dept Biomed Sci, Child & Adolescent Neuropsychiat Unit, Cagliari, Italy
[9] Shire, Lexington, MA USA
[10] Univ Dundee, Div Neurosci, Dundee, Scotland
来源：
EUROPEAN PSYCHIATRY | 2017年 / 41卷
关键词：
D O I：
10.1016/j.eurpsy.2017.01.1943
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EW0074
引用
收藏
页码：S130 / S130
页数：1
相关论文
共 50 条
  • [31] Effect of lurasidone on cognition in adolescents with schizophrenia: A one-year interim analysis of a 2-year open-label extension study
    Harvey, P. D.
    Goldman, R.
    Tocco, M.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2018, 48 : S123 - S123
  • [32] A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF LISDEXAMFETAMINE DIMESYLATE IN 4-TO 5-YEAR-OLD CHILDREN WITH ADHD
    Childress, Ann Catherine
    Lloyd, Eric
    Jacobsen, Leslie
    Gunawardhana, Lhanoo
    Findling, Robert L.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2020, 59 (10): : S149 - S149
  • [33] Pharmacokinetics of Lisdexamfetamine Dimesylate and Its Active Metabolite, d-Amphetamine, With Increasing Oral Doses of Lisdexamfetamine Dimesylate in Children With Attention-Deficit/Hyperactivity Disorder: A Single-Dose, Randomized, Open-Label, Crossover Study
    Boellner, Samuel W.
    Stark, Jeffrey G.
    Krishnan, Suma
    Zhang, Yuxin
    CLINICAL THERAPEUTICS, 2010, 32 (02) : 252 - 264
  • [34] SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION: INTERIM ANALYSIS OF A 2-YEAR OPEN-LABEL EXTENSION STUDY
    DelBello, M. P.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    Coghill, D.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 144 - 144
  • [35] Effect of lurasidone on neurocognitive performance in children and adolescents with bipolar depression: interim analysis at week 52 of a 2-year open-label extension study
    Burdick, K. E.
    Goldman, R.
    Tocco, M.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    BIPOLAR DISORDERS, 2018, 20 : 68 - 69
  • [36] EFFICACY OF LONG-TERM TREATMENT WITH LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION: INTERIM ANALYSIS OF A 2-YEAR OPEN-LABEL EXTENSION STUDY
    DelBello, M. P.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 143 - 144
  • [37] Effect of lurasidone on cognition in children and adolescents with bipolar depression: A 6-month interim analysis of a 2-year open-label extension study
    Burdick, K. E.
    Goldman, R.
    Tocco, M.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2018, 48 : S79 - S79
  • [38] Lisdexamfetamine dimesylate effects on the pharmacokinetics of cytochrome P450 substrates in healthy adults in an open-label, randomized, crossover study
    Ermer J.
    Corcoran M.
    Martin P.
    Drugs in R&D, 2015, 15 (2) : 175 - 185
  • [39] Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study (pg 1, 2020)
    Correll, Christoph U.
    Findling, Robert L.
    Tocco, Michael
    Pikalov, Andrei
    Deng, Ling
    Goldman, Robert
    CNS SPECTRUMS, 2022, 27 (01) : 129 - 129
  • [40] Long-Term, Open-Label Extension Study of Guanfacine Extended Release in Children and Adolescents with ADHD
    Biederman, Joseph
    Melmed, Raun D.
    Patel, Anil
    McBurnett, Keith
    Donahue, Jessica
    Lyne, Andrew
    CNS SPECTRUMS, 2008, 13 (12) : 1047 - 1055
12345